Skip Main Navigation
Page Content

Save This Event

Event Saved

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)

ComplianceOnline

Monday, June 26, 2017 at 8:30 AM - Tuesday, June 27, 2017 at 4:30 PM (CEST)

Process Validation Guidance Requirements (FDA and EU...

Ticket Information

Ticket Type Sales End Price Fee Quantity
Seminar One Registration (USD) (early bird price)
For Registrations after June 5, 2017 - $2299
Jun 26, 2017 $1,899.00 $0.00
Seminar One Registration (USD) Jun 26, 2017 $2,299.00 $0.00

Who's Going

Loading your connections...

Share Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)

Event Details

The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). These guidances align Process Validation activities with a product lifecycle concept and with existing FDA and EU guidances, including the FDA/International Conference on Harmonization (ICH), Guidance for Industry, Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The lifecycle concept, new to these Guidances, link product and process development, qualification of the commercial manufacturing process, and maintenance of the process in a state of control during routine commercial production. These guidances also support process improvement and innovation through sound science and risk management. The new Process Validation Guideline/Practice incorporate elements of Process Validation as early as the Research and Development phase, and continues onward through Technology Transfer, into the Phase 1 IND Clinical Trial manufacturing phase, and ultimately into Phase 2 and 3, and then commercial manufacturing.

Each facility, whether producing small or large molecules requires both an overall Site Validation Plan as well as specific validation plans to manage the multiplicity of validations required to confirm the successful manufacture of each of its products.

This two day, interactive Seminar which provides a conduit to enhance your understanding of the Continued Process Verification, will be reviewed in detail: where does it begin; what is included; and, when does it end.

Common questions asked by the users of Process Validation include;

  • How does one integrate these two different concepts (Phase 1, 2, and 3 vs. Stages 1, 2, and 3) and where do they merge?
  • Do they exist independently of each other or do they complement each other to enhance, build and provide a product that neither alone could. Questions that may arise include where are cGMPs initiated?
  • To what extent must they be used? Since Stage 3 extends through commercial batch manufacturing, what happens to Phase 3?
  • Does it follow along or with Stage 3? Questions that exist include how one manages special situations to include viral inactivation and removal, impurity clearance, process consistency, process solution stability, endotoxin, bioburden, and other miscellaneous cell culture tests to include DNA and host cell protein.

These questions will be addressed within Stage 2 as presented here and include utilization of Process Validation and Phase 1, 2 and 3, where their Guidances blend and where they remain distinct. In particular, Stage 3.

Important: Please plan to bring a multidisciplinary group from your Company to gain the most from this very important seminar.

Who Will Benefit:

Those who will benefit from this seminar include

  • Product Development
  • Project Management
  • Regulatory Compliance
  • Quality Assurance
  • Quality Control

 

For Registrationhttps://www.complianceonline.com/fda-eu-annex15-ich-process-validation-qualification-cgmp-ppq-seminar-training-80440SEM-prdsm?channel=eventbrite          

 

Note: Use coupon code  NB5SQH8N  and get 10% off on registration.

Have questions about Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)? Contact ComplianceOnline

Save This Event

Event Saved

When & Where


Vienna

Vienna
Austria

Monday, June 26, 2017 at 8:30 AM - Tuesday, June 27, 2017 at 4:30 PM (CEST)


  Add to my calendar

Organizer

ComplianceOnline

Enhancing global compliance, creating a world where quality and compliance professionals, regulators, and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates, ensuring continuous improvement in global operations, quality & safety.

Making sure that we are responsible corporate citizens helping our constituents build a more responsible enterprise, one which operates with high quality , under a code of ethics, and with process discipline to ensure greater shareholder returns.

Keeping things simple and straight forward , so that we all can indeed improve the quality of our processes, our work, our businesses and enhance compliance globally.

Being inclusive, giving the process experts ( & novices! ), compliance professionals, quality champions, and regulatory agencies a voice so that all of us can contribute and make a difference.

  Contact the Organizer
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
Things to do in Vienna Conference Science & Tech

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.